Many thanks to Sanofi for joining BioFIT 2018 as a Gold Sponsor!
Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people they serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare.
Join key BioFIT 2018 sponsors such as Pfizer, Bayer, Roche, MSD, Boehringer Ingelheim, LFB, GENFIT, VIB and Sanofi to have the opportunity to:
Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
Highlight your interest in early-stage innovation
Present your ideas and technologies to key innovation players in Life Sciences
Enhance your visibility on an international scale and be recognised as a key innovative actor
Show your expertise thanks to specific communication tools
Boehringer Ingelheim knows what it takes to be innovative and entrepreneurial. From the small factory in 1885 to today’s global pharmaceutical organisation, we know how important it is to nurture and develop emerging science and technology.
Our track record of bringing breakthrough medicines to patients starts with new ideas and new science, and collaborations with external partners play a key role in helping us deliver an innovation-led portfolio. Join us at our partnering day to explore how we can develop the next generation of medicines together.
For more information on our partnering interests please visit: www.boehringer-ingelheim.com/partnering/interests.
Meet our research and partnering team
Research and partnering teams will be available throughtout the day for networking.
Many thanks to GENFIT for joining BioFIT 2018 as a Bronze Sponsor!
GENFITis a biopharmaceutical company at the forefront of developing therapeutic and diangostics solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology.
Join key BioFIT 2018 sponsors such as Pfizer, Bayer, Roche, MSD, Boehringer Ingelheim, LFB, GENFIT and VIB to have the opportunity to:
Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
Highlight your interest in early-stage innovation
Present your ideas and technologies to key innovation players in Life Sciences
Enhance your visibility on an international scale and be recognised as a key innovative actor
Show your expertise thanks to specific communication tools
They were the BioFIT 2017 sponsors: Sanofi, Pfizer, Bayer, Genfit, Lilly, MSD, Merck, Boehringer Ingelheim, Johnson & Johnson Innovation, Novo Nordisk, LFB, PPRS and Trianni.
The European Genomic Institute for Diabetes (EGID) will host its 5th international symposium: the gut, incretins and diabetes, from December 4th, 2018, Lille.
This biennial event brings an international focus to our work by the joining of the IDEA Summit and the EGID symposium.
The committee and speakers are world leaders in their fields and will present the latest scientific advances in diabetes and related disorders.
This symposium provides an opportunity for young researchers to present their work via poster presentation and to win the “Best Poster Award” of up to 1000 euros.
Conference Programme:
8.30 – 9.15 AM
WELCOME COFFEE & SYMPOSIUM MATERIAL DISTRIBUTION
9.15 – 9.30 AM
INTRODUCTION AND WELCOMING
9.30 – 10.15 AM
INSIGHTS FROM BARIATRIC SURGERY
RACHEL BATTERHAM Professor of Obesity, Diabetes and Endocrinology – NIHR Research Professor, Head of UCLH Obesity & Bariatric Services, Head of Center for Obesity Research, Department of Medicine, Rayne Building, University College London
10.15 – 11.00 AM
FOOD AND TYPE 2 DIABETES: RESTORING THE INSIDE OF THE SYSTEM
ROY TAYLOR Professor of Medicine and Metabolism, Magnetic Resonance Centre, Campus for Ageing and Vitality, Newcastle upon Tyne
11.00 – 11.30 AM
EGID POSTER SESSION
11.30 AM – 1.00 PM
BIOFIT PLENARY SESSION: Seed funds crossing borders: How far and how fast is the early-stage investment market in Biotech globalising?
1:00 PM – 2.30 PM
LUNCH
2.30 – 3.15 PM
INCRETINS, DIABETES AND CV DISEASE
NIKOLAUS MARX Director of the Medical Cardiology Clinic – Cardiology, pneumonology, angiology, internal intensive care Aachen University Hospital
3.15 – 4.00 PM GUT-BRAIN GLUCOSE SIGNALING IN THE CONTROL OF ENERGY HOMEOSTASIS
GILLES MITHIEUX Research Director – CNRS Director of U1213, Nutrition, Diabetes and the Brain
4.00 – 4.30 PM
NETWORKING BREAK
4.30 – 5.15 PM
THERAPEUTIC POTENTIAL OF MULTI-INCRETIN THERAPY – FROM MICE TO MEN
AIMO KANNT Head of Department, General Metabolism & Obesity, Sanofi
5.15 – 5.30 PM
BEST PAPER AWARD
5.30 – 6.00 PM
CONCLUSION & INVITATION TO THE CHEESE AND WINE COCKTAIL
BioFIT and the WBC Incubator are pleased to announce that they will be putting together a special edition of WBC Club during BioFIT 2018 in Lille. This session, called «Would-be CEO Networking Lunch», will be held on the second day of BioFIT (5th December).
As talented CEOs are so much sought-after by so many stakeholders of the biotech industry, to both launch and drive new companies to success, this special WBC Club session will bring together representatives of emerging start-ups, technology transfer offices, incubators and investing networks as well as CEOs and would-be CEOs to address this crucial issue.
Since 2010, WBC Incubator has validated close to 100 biotech professionals in Belgium for their ability to match and work with scientific founders and entrepreneurs with the collective aim to build together more exciting business plans, stronger investment propositions and faster business development programmes. In Belgium, biotech CEOs and Would-be CEOs meet regularly to discuss business opportunities during so-called WBC Club events.
The «Would-be CEO Networking Lunch» is organised to present the WBC incubation model to BioFIT participants. Please also note that Would-be CEOs will be identified using the BioFIT partnering platform.
Any bioentrepreneur looking for a project to get involved in is welcome to join BioFIT and particularly this would-be CEOs networking lunch. Any incubator or tech transfer entity looking for an entrepreneur to lead their start-up launch projects is also welcome to join.
In 5 days, it will be too late to enjoy the Early Bird offer!
If you are interested in attending BioFIT on 4th and 5th December 2018 in Lille, France, enjoy the Early Bird offer before it ends, after this Saturday it will be too late!
As an Exhibitor, you will gain high visibility among top leaders in the Life Sciences sector. Ideally located at the focal point of the event, the Exhibition area enables participants to access key information, expand their network, highlight their skills, services and innovations and enhance their visibility.
Many thanks to VIB for joining BioFIT 2018 as a Bronze Sponsor!
VIB is a life sciences research institute, based in Flanders, Belgium. They perform basic research with a strong focus on translating scientific results into pharmaceutical, agricultural and industrial applications.
Join key BioFIT 2018 sponsors such as Bayer,Roche, MSD, Boehringer Ingelheim, Pfizer and LFB, to have the opportunity to:
Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
Highlight your interest in early-stage innovation
Present your ideas and technologies to key innovation players in Life Sciences
Enhance your visibility on an international scale and be recognised as a key innovative actor
Show your expertise thanks to specific communication tools
They were the BioFIT 2017 sponsors: Sanofi, Pfizer, Bayer, Genfit, Lilly, MSD, Merck, Boehringer Ingelheim, Johnson & Johnson Innovation, Novo Nordisk, LFB, PPRS and Trianni.
BioFIT 2018 will host the 4th edition of the “R&D dating for Animal Health and Innovation” business convention, at the French association for the animal healthcare industry (SIMV)’s initiative, on the 4th and 5th of December 2018, in Lille.
Today, public-private and private-private partnerships are thought to be the leverage that is needed for innovation. That is why the SIMV launched the “R&D dating for Animal Health and Innovation”, which strives to initiate high-level exchanges between research departments of the veterinary medicine and diagnostics industry and public research, as well as with biotechnology companies (start-ups).
By enabling face-to-face encounters, the event will enhance the visibility of cutting-edge research in France and in Europe, encourage investments and lead to therapeutic innovation.
About SIMV
While being the organiser of this meeting, the SIMV intends to federate research actors by actively contributing to meet the needs in animal health innovation. In particular, enhanced research is needed to supplement and renew the therapeutic arsenal for the treatment of infectious diseases and therefore research and innovation on this topic should be promoted.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.